RSS   Newsletter   Contact   Advertise with us
Post Online Media

AxoGen appoints Amy Wendell to board of directors

AxoGenAxoGen, a surgical solutions company, announced the election of Amy Wendell to its board of directors.

Ms. Wendell was also appointed to the Company’s Compensation and Governance Committees.

Article continues below

READ MORE AxoGen appoints senior vice president of sales

Most recently, Ms. Wendell served as Covidien’s Senior Vice President of Strategy and Business Development where she led the company’s strategic planning and portfolio management functions, including licensing, distribution and market intelligence.

Ms. Wendell joined Covidien, formerly known as Tyco Healthcare/Kendall, in 1986 and she held roles of increasing responsibility up through its acquisition by Medtronic in January 2015.

Since 2015, Ms. Wendell has been a Senior Advisor for McKinsey’s Strategy and Corporate Finance Practice and also serves as a member of McKinsey's Transactions Advisory Board.

Since January 2016, she has also been a Senior Advisor for Perella Weinberg Partners’ Healthcare Investment Banking Practice. Ms. Wendell is also a member of the board of directors of Ekso Bionics

She holds a Bachelor of Science degree in Mechanical Engineering from Lawrence Technological University and a Master of Science degree in Biomedical Engineering from the University of Illinois.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy